Tag: form

SOUTH SAN FRANSCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of  engineered T cell therapeutics that deploy phagocytic mechanisms, announces that the U.S. Food and Drug Administration (FDA) has granted CERo’s Orphan Drug Designation (ODD) for the company's lead drug candidate CER-1236, for the treatment of acute myeloid leukemia (AML). CER-1236 is an innovative therapy that engineers a cancer patient's own T cell therapeutics that deploy phagocytic (i.e., target-cell eating) mechanisms alongside the array of built-in target cell destroying mechanisms used by T cells.

- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications -

MIAMI, June 17, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 83^rd Emerging Growth Conference on June 17 & 18, 2025.

High-volume asset gives Company a foothold in one of the strongest performing retail corridors in the trade area

Realkredit Danmark A/S hereby publishes a new Base Prospectus for mortgage covered bonds and mortgage bonds.

The base prospectus is available in electronic form on Realkredit Danmark's website at www.rd.dk/Investor

If you have any questions, please contact:

Hella Gebhardt Ronnebaek, Chief Analyst, HGEB@rd.dk
Mathias Kofoed Mortensen, Senior Corporate Governance Legal Advisor, MKMO@rd.dk